Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization.
about
Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Antithrombotic therapy in pati ...... eparin during hospitalization.
@ast
Antithrombotic therapy in pati ...... eparin during hospitalization.
@en
type
label
Antithrombotic therapy in pati ...... eparin during hospitalization.
@ast
Antithrombotic therapy in pati ...... eparin during hospitalization.
@en
prefLabel
Antithrombotic therapy in pati ...... eparin during hospitalization.
@ast
Antithrombotic therapy in pati ...... eparin during hospitalization.
@en
P2093
P2860
P356
P1476
Antithrombotic therapy in pati ...... eparin during hospitalization.
@en
P2093
Jeffrey N Kaiser
Jonathan A Gutman
Kathryn L Hassell
Katrina M Babilonia
Larry K Golightly
Patrick M Klem
Toby C Trujillo
P2860
P304
P356
10.1177/1076029614543140
P577
2014-07-14T00:00:00Z